ArticleJournal of medical Internet research2025
Exploration of Reproductive Health Apps' Data Privacy Policies and the Risks Posed to Users: Qualitative Content Analysis.
Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Dual-Source Retrieval-Augmented Generation Chatbot for Women's Health (HerCare): Design and Multimethod Evaluation Study.JMIR formative research · 2026Article
- Perceived Sensitivity of Sensor-Based Digital Health Data: Qualitative Interview Study.JMIR mHealth and uHealth · 2026Article
- Reimagining maternal and infant wellbeing through AI-embedded integrative arts-based care: a public health perspective.Frontiers in public health · 2026Article
- Anemia in young women: determinants and artificial intelligence-based management approaches.Frontiers in artificial intelligence · 2026Review
- Maternal mHealth usability strengthened by trust, governance, and navigation.Frontiers in digital health · 2026Article
- Acceptability and Use of Digital Health and Artificial Intelligence-Enabled Chatbots for Sexual and Reproductive Health Among Lesbian, Bisexual, and Queer Women of Color in the United States: Cross-Sectional Survey Study.Journal of medical Internet research · 2025Article
- Populations and Health Domains Served by Direct-to-Consumer Digital Health Companies in the United States, 2011-2023: Cross-Sectional Study.JMIR formative research · 2025Article
- Development prospects of "Internet + medical and health services" in Shandong: application status and public acceptance.Frontiers in public health · 2025Article
- Flowing data: women's views and experiences on privacy and data security when using menstrual cycle tracking apps.Oxford open digital health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMobile health apps often require the collection of identifiable information. Subsequently, this places users at significant risk of privacy breaches when the data are misused or not adequately stored and secured. These issues are especially concerning for users of reproductive health apps in the United States as protection of sensitive user information is affected by shifting governmental regulations such as the overruling of Roe v Wade and varying state-level abortion laws. Limited studies have analyzed the data privacy policies of these apps and considered the safety issues associated with a lack of user transparency and protection.
objectiveThis study aimed to evaluate popular reproductive health apps, assess their individual privacy policies, analyze federal and state data privacy laws governing these apps in the United States and the European Union (EU), and recommend best practices for users and app developers to ensure user data safety.
methodsIn total, 4 popular reproductive health apps-Clue, Flo, Period Tracker by GP Apps, and Stardust-as identified from multiple web sources were selected through convenience sampling. This selection ensured equal representation of apps based in the United States and the EU, facilitating a comparative analysis of data safety practices under differing privacy laws. A qualitative content analysis of the apps and a review of the literature on data use policies, governmental data privacy regulations, and best practices for mobile app data privacy were conducted between January 2023 and July 2023. The apps were downloaded and systematically evaluated using the Transparency, Health Content, Excellent Technical Content, Security/Privacy, Usability, Subjective (THESIS) evaluation tool to assess their privacy and security practices.
resultsThe overall privacy and security scores for the EU-based apps, Clue and Flo, were both 3.5 of 5. In contrast, the US-based apps, Period Tracker by GP Apps and Stardust, received scores of 2 and 4.5, respectively. Major concerns regarding privacy and data security primarily involved the apps' use of IP address tracking and the involvement of third parties for advertising and marketing purposes, as well as the potential misuse of data.
conclusionsCurrently, user expectations for data privacy in reproductive health apps are not being met. Despite stricter privacy policies, particularly with state-specific adaptations, apps must be transparent about data storage and third-party sharing even if just for marketing or analytical purposes. Given the sensitivity of reproductive health data and recent state restrictions on abortion, apps should minimize data collection, exceed encryption and anonymization standards, and reduce IP address tracking to better protect users.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.